BiotechTube
Home/N-Zyme Biotec/Nikki Johnston, Ph.D.
NJ

Nikki Johnston, Ph.D.

Co-Founder and Chief Scientific Officer

N-Zyme Biotec

Therapeutic Areas

GastroenterologyOtolaryngology

N-Zyme Biotec Pipeline

DrugIndicationPhase
Fosamprenavir (Repurposed)Laryngopharyngeal Reflux (LPR)Phase 3
Fosamprenavir SR Oral FormulationLPR / GERDPre-clinical
Fosamprenavir Dry Powder InhalerLPR / Airway RefluxPre-clinical

Leadership Team at N-Zyme Biotec

FV
Franco Vigile
Co-Founder and CEO
View full N-Zyme Biotec profile